Harvard Bioscience Rallies After Q3 Earnings Report

Harvard Bioscience’s stock price improved 9 percent in the past week, as the BioCommerce Week Index posted a second consecutive week of gains.

Led by Harvard Bio, 13 of the 15 companies on the BCW Index saw their stock prices rise over the previous week’s close.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.